OOIR: Observatory of International Research

Papers

(The H4-Index of Biochimica et Biophysica Acta-Reviews on Cancer is 41. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)

Article	Citations
Tumour cell-induced platelet aggregation in breast cancer: Scope of metal nanoparticles	360
Microbial influence on triggering and treatment of host cancer: An intestinal barrier perspective	244
Is tumour-expressed aminopeptidase N (APN/CD13) structurally and functionally unique?	178
Advances in epigenetic modifications and cervical cancer research	160
Modeling bladder cancer in the laboratory: Insights from patient-derived organoids	152
TSPAN1, a novel tetraspanin member highly involved in carcinogenesis and chemoresistance	148
miRNAs and androgen deprivation therapy for prostate cancer	121
The interaction of SET and protein phosphatase 2A as target for cancer therapy	101
Nutrition and dietary restrictions in cancer prevention	100
Reflections on drug resistance to KRAS inhibitors and gene silencing/editing tools for targeting mutant KRAS in cancer treatment	97
Uveal melanoma modeling in mice and zebrafish	91
ESR1 activating mutations: From structure to clinical application	89
Progress and challenges of immunotherapy in triple-negative breast cancer	85
Decoding the role of FOXP3 in esophageal cancer: Underlying mechanisms and therapeutic implications	76
Prostate cancer: Molecular aspects, consequences, and opportunities of the multifocal nature	75
Targeting lipid metabolism in cancer metastasis	71
Transcription factors in glioblastoma – Molecular pathogenesis and clinical implications	68
In what area of biology has a “new” type of cell death been discovered?	67
Extracellular vesicles in cancer therapy: Roles, potential application, and challenges	65
Dual perspective on autophagy in glioma: Detangling the dichotomous mechanisms of signaling pathways for therapeutic insights	60
Insights into the role of connexins and specialized intercellular communication pathways in breast cancer: Mechanisms and applications	60
Epigenetic changes associated with Bacillus Calmette-Guerin (BCG) treatment in bladder cancer	60
Contribution of CXCR3-mediated signaling in the metastatic cascade of solid malignancies	55
Biomarkers in high grade serous ovarian cancer	54
S100A8 and S100A9 in Cancer	52

Long non-coding RNAs: Fundamental regulators and emerging targets of cancer stem cells	50
Advances and prospects of mRNA vaccines in cancer immunotherapy	49
Mitochondrial metabolism in laryngeal cancer: Therapeutic mechanisms and prospects	48
Tumor suppressor p53: Biology, signaling pathways, and therapeutic targeting	46
Enhancing the anti-tumor response by combining DNA damage repair inhibitors in the treatment of solid tumors	45
Prognostic features of the tumour microenvironment in oesophageal adenocarcinoma	45
The interplay of obesity, microbiome dynamics, and innovative anti-obesity strategies in the context of endometrial cancer progression and therapeutic approaches	45
Multiple therapeutic approaches of glioblastoma multiforme: From terminal to therapy	45
Targeting Cdc20 for cancer therapy	44
Recent insights into RNA m5C methylation modification in hepatocellular carcinoma	44
Multifaceted roles of neutrophils in tumor microenvironment	44
Small non-coding RNAs and pancreatic ductal adenocarcinoma: Linking diagnosis, pathogenesis, drug resistance, and therapeutic potential	43
Multiple impacts of Naa10p on cancer progression: Molecular functions and clinical prospects	42
Interleukin-21 as an adjuvant in cancer immunotherapy: Current advances and future directions	42
Long non-coding RNAs: A view to kill ovarian cancer	42
Editorial Board	41